1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account
China Research & Intelligence Co., Ltd. Logo

Price Adjustment of 14 Kinds of National Immunization Program (NIP) Vaccines in China

Generally, high-price vaccines have a price reduction and low-price vaccines have a rising price. High-price products like Measles Mumps& Rubella Vaccine Live and Measles & Rubella Combined Vaccine (MR) have a price reduction of 35% and 47%.

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Sep 10, 2009 -
www.shcri.com -- At the end of July of 2009, the National Development & Reform Commission of China issued the “General Office of the National Development & Reform Commission’s Notification on the Price Adjustment of Recombinant Hepatitis B Vaccine and Other 13 Kinds of NIP Vaccines”. According to the notification, 14 kinds of NIP vaccines’ prices will have a varying degree of adjustments, including “Recombinant Hepatitis B Vaccine”, “Live Attenuated Polio Vaccine Candy”, “Diphtheria, Tetanus and Pertussis Combined Vaccine, Adsorbed”, “Live Attenuated Measles Vaccine”, “Measles Mumps and Rubella Vaccine Live” and “Japanese Encephalitis Vaccine, Live”.

Chart Cost Prices of 14 Kinds of NIP Vaccines (tax included)
Serial Number   Adopted Drug Name   Medicament Form    Single-dose Dosage   Cost Price (Unit in USD)

1    Recombinant Hepatitis B Vaccine   Liquid preparation    5ug    0.278
         10ug    0.454
         20ug    0.571
2    Intradermal injection of BCG   Lyophilized preparation   0.1ml    0.110
3    Live Attenuated Polio Vaccine Candy   Sugar-pill   1 pill   0.078
   Live Attenuated Oral Poliomyelitis Vaccine   Liquid preparation   0.1ml    0.142
4    Diphtheria,Tetanus and AcelluIar Pertussis Combined Vaccine,Adsorbed   Liquid preparation   0.5ml    0.498
   Diphtheria, Tetanus and Pertussis Combined Vaccine, Adsorbed   Liquid preparation   0.5ml    0.041
5    Diphtheria and Tetanus Combined Vaccine, Adsorbed   Liquid preparation   0.5ml    0.047
6    Live Attenuated Measles Vaccine   Lyophilized preparation   0.5ml    0.161
7    Measles Mumps and Rubella Vaccine Live   Lyophilized preparation   0.5ml    3.045
   Measles and Rubella Combined Attenuated Live Vaccine, MR   Lyophilized preparation    0.5ml    0.849
   Measles and Mumps Combined Vaccine,Live   Lyophilized preparation   0.5ml    0.820
8    Japanese Encephalitis Vaccine,Live   Lyophilized preparation   0.5ml    1.054
      Liquid preparation   0.5ml    0.952
   Inactivated Japanese Encephalitis Vaccine (Inactivated JE Vaccine)   Lyophilized preparation   0.5ml    1.054
9    Group A Meningococcal Polysaccharide Vaccine   Lyophilized preparation   30ug    0.102
10    Group A & Group C Meningococcal Glycoconjugate Vaccine   Lyophilized preparation   10ug    1.537
   Meningococcal Group A&C Meningococcal Polysaccharide Conjugate Vaccine   Lyophilized preparation   100ug    0.512
11    Attenuated Hepatitis A Vaccine,Live   Lyophilized preparation   1ml    2.855
   Inactivated Hepatitis A Vaccine     Liquid preparation   0.5ml    4.700
12    Bivalent Purified Hemorrhagic Fever with Renal Syndrome Vaccine   Liquid preparation   1ml    1.245
13    Anthrax Vaccine (Live) for Percutaneous Scarification      0.05ml    2.240
14    Leptospirosis Vaccine   Liquid preparation   0.5ml    0.073

In May of 2009, the National Development and Reform Commission of China held a charrette on planning the price reform of immune drugs. In July, it published the notification on declining drug prices, adjusting prices of14 kinds of immunization program vaccines.

Generally, high-price vaccines have a price reduction and low-price vaccines have a rising price. High-price products like Measles Mumps& Rubella Vaccine Live and Measles & Rubella Combined Vaccine (MR) have a price reduction of 35% and 47%. The prices of low-price vaccines like Live Attenuated Polio Vaccine Candy and Group A Meningococcal Polysaccharide Vaccine rise by 112% and 40% respectively.

The price adjustment measure will have a great impact on enterprises manufacturing a large proportion of these vaccines.

This time, the National Development and Reform Commission of China adjusts prices of NIP vaccines in the situation of new Chinese medical reform. By administrative means, the government reduces profits of pharmaceutical producing enterprises, as well as the costs that are used by the government to improve the public health service.

Chinese government might enlarge the scope to reduce prices of government purchasing drugs. After all, in the current industrial environment, the government bears some pressure on paying for the medical reform. Transferring partial reform costs to manufacture enterprises might be a choice for the government. In the future, prices of medical products with high homogenization and low added values are expected to be reduced more obviously. A new round of drug price cuts based on the survey of drug costs will come.

Source: China Research and Intelligence
If you'd like to copy or quote this article, please keep the source information

More information can be browsed:
http://www.shcri.com/reportdetail.asp?id=218

# # #

The primary and secondary research was conducted by consultants in China who know the industry and the local markets well.

--- end ---

Click to Share

Contact Email:
***@shcri.com
Source:www.shcri.com
Phone:+86-21-6852-1029-601
Fax:+86-21-6852-1029-604
Zip:200124
City/Town:Pudong
State/Province:Shanghai
Country:China
Industry:Biotech, Health, Medical
Tags:nip vaccines, , medical reform
Last Updated:Sep 10, 2009
Shortcut:http://prlog.org/10337680
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share